Cost considerations Pharmaceutical semaglutide (Wegovy): $1,300-1,500/month without insurance Insurance may cover (varies) Patient assistance programs available Research semaglutide: $150-300/month No insurance No patient assistance User assumes risk Research cagrilintide: $200-400/month Not prescription available yet Higher cost due to limited availability Total CagriSema combination cost (research chemicals): $350-700/month Both peptides at full dose Significant investment Compare to bariatric surgery ($15,000-25,000 upfront) Budget planning: Year 1 (titration + maintenance): $4,200-8,400 Ongoing maintenance: $350-700/month Consider reducing to maintenance doses May need 12-24+ months total Use our peptide cost calculator to budget protocols
effects on fat metabolism in humans are still being characterised and should not be overstated Glucagon receptor increases energy expenditure and promotes fat breakdown, though it may also raise hepatic glucose output
The fast-absorbing formula spreads easily over the skin without leaving a sticky or greasy residue, making it suitable for everyday use at home, work, or after physical activity
For people managing the full complexity of semaglutide protocols, understanding both sides of what this medication does and does not do in various testing scenarios is part of being an informed user